The primary aim of the study was to assess whether D-Dimer level at entry or an increase of D-Dimer level during the follow-up could predict the occurrence of subsequent cardiovascular events in patients with atrial fibrillation.
Patients will be followed-up every 4 months with clinical assessment and D-dimer blinded measurement.
Study Type
OBSERVATIONAL
Enrollment
425
AP HP
Paris, France
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.